Genotoxicity and carcinogenicity studies of antihistamines

Archives of Toxicology

Volumn 85, Issue 10, 2011, Pages 1173-1187

  Brambilla, Giovanni ^a   Mattioli, Francesca ^a   Robbiano, Luigi ^a   Martelli, Antonietta ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Antihistamines; Carcinogenicity; Genotoxicity

Indexed keywords

ACRIVASTINE; ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZELASTINE; CETIRIZINE; CHLORCYCLIZINE; CHLORPHENIRAMINE; CYPROHEPTADINE; DEPTROPINE; DESLORATADINE; DIPHENHYDRAMINE; DOXYLAMINE; EBASTINE; EPINASTINE; FEXOFENADINE; LORATADINE; MEPYRAMINE; METHAPYRILENE; METHDILAZINE; MIZOLASTINE; PHENINDAMINE; PHENIRAMINE; PHENYLTOLOXAMINE; PROMETHAZINE; SETASTINE; TERFENADINE; THENYLDIAMINE; TRIPELENNAMINE; TRIPROLIDINE; UNINDEXED DRUG;

CARCINOGEN TESTING; CARCINOGENICITY; CHROMOSOME ABERRATION; GENE MUTATION; GENOTOXICITY; HUMAN; MICRONUCLEUS TEST; NONHUMAN; PRIORITY JOURNAL; REVIEW; TOXICITY TESTING;

ANIMALS; CARCINOGENICITY TESTS; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; MALE; MICE; MUTAGENICITY TESTS; RATS;

MUS; RATTUS;

EID: 80855128737     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-011-0659-4     Document Type: Review

References (73)

1. FR Althaus SD Lawrence GL Sattler HC Pitot 1982 DNA damage induced by the antihistaminic drug methapyrilene hydrochloride Mutat Res 103 213 218 6123945 10.1016/0165-7992(82)90045-8 1:CAS:528:DyaL38XhtlGlt78%3D (Pubitemid 12222550)
2. BE Anderson E Zeiger MD Shelby MA Resnick DK Gaulati JL Ivett KS Loveday 1990 Chromosome aberration and sister chromatid exchange test results with 42 chemicals Environ Mol Mutagen 16 suppl 18 55 137 2091924 10.1002/em.2850160505 1:CAS:528:DyaK3MXhvFaktQ%3D%3D (Pubitemid 20376836)
3. AW Andrews W Lijinsky SW Snyder 1984 Mutagenicity of amine drugs and their products of nitrosation Mutat Res 135 105 108 6363913 10.1016/0165- 1218(84)90162-9 1:CAS:528:DyaL2cXhsFSlt7w%3D (Pubitemid 14186544)
4. J Ashby RD Callander D Paton E Zeiger F Ratpan 1988 Weak and unexpected mutagenicity to Salmonella of the rat hepatocarcinogen methapyrilene Environ Mol Mutagen 12 243 252 3044785 1:CAS:528:DyaL1cXlsVCnsrw%3D
5. J Benze L Gypen J Vanderberghe A Lampo R De Coster C Bowden H Van Cauteren 1995 Carcinogenicity studies of astemizole in mice and rats Cancer Res 55 5589 5594 7585639 1:CAS:528:DyaK2MXps1Krtbw%3D
6. G Brambilla A Martelli 2007 Genotoxic and carcinogenic risk to humans of drug-nitrite interaction products Mutat Res 635 17 52 17157055 10.1016/j.mrrev.2006.09.003 1:CAS:528:DC%2BD2sXht1CntA%3D%3D (Pubitemid 46482377)
7. JD Budroe JG Shaddock DA Casciano 1984 A study of the potential genotoxicity of methapyrilene and related antihistamines using the hepatocyte/DNA repair assay Mutat Res 135 131 137 6141525 10.1016/0165-1218(84) 90166-6 1:CAS:528:DyaL2cXhtlans74%3D (Pubitemid 14186548)
8. DA Casciano HM Schol 1984 Methapyrilene is inactive in the hepatocyte-mediated Chinese hamster ovary/hypoxanthine-guanine phosphoribosyl transferase mutational assay Cancer Lett 21 337 341 6537895 10.1016/0304- 3835(84)90014-4 1:CAS:528:DyaL2cXhtlCjtbc%3D (Pubitemid 14158510)
9. DA Casciano G Talaska D Clive 1991 The potent carcinogen methapyrilene induces mutations in the L5178Y mouse lymphoma cells in the apparent absence of DNA adduct formation Mutat Res 263 127 132 2046705 10.1016/0165-7992(91)90070-K 1:CAS:528:DyaK3MXks1Clsb4%3D
10. Council Directive 65/65/EEC of the European Economic Community of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products (1965)
11. Y Fujioka H Maizumi 1983 Further studies on mutagenicity of chlorpromazine and promethazine Shigaku 71 141 142 1:CAS:528:DyaL2cXls1ems7s%3D
12. SM Galloway MJ Armstrong C Reuben S Colman B Brown C Cannon AD Bloom F Nakamura M Ahmed S Duk J Rimpo BH Margolin MA Resnick B Anderson E Zeiger 1987 Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals Environ Mol Mutagen 10 suppl 10 1 175 3319609 10.1002/em.2850100502 1:CAS:528:DyaL2sXlvFaksb4%3D (Pubitemid 18039247)
13. JP Gibson KW Huffmann JW Newberne 1982 Preclinical safety studies with terfenadine Arzneim-Forsch 32 1179 1184 1:CAS:528:DyaL38XmtVyju7w%3D (Pubitemid 12035872)
14. E Gocke 1996 Review of the genotoxic properties of chlorpromazine and related phenothiazines Mutat Res 366 9 21 8921984 (Pubitemid 26371137)
15. DL Greenman R Allen R Dahlgren GM Cronin WT Allaben 1995 Chronic toxicity/carcinogenicity study of pyrilamine in B6C3F1 mice J Am Coll Toxicol 14 148 157 1:CAS:528:DyaK2MXls1CntL0%3D
16. DL Greenman GM Cronin R Dahlgren R Allen W Allaben 1995 Chronic feeding study of pyrilamine in fisher 344 rats Fundam Appl Toxicol 25 1 8 7601318 10.1006/faat.1995.1034 1:CAS:528:DyaK2MXkvFaqt7s%3D
17. DL Greenman W Sheldon G Schieferstein R Allen WT Allaben 1995 Chronic study of triprolidine for oncogenicity in mice Fundam Appl Toxicol 25 138 145 7601321 10.1006/faat.1995.1047 1:CAS:528:DyaK2MXkvFaqtLY%3D
18. DL Greenman W Sheldon G Schieferstein R Allen WT Allaben 1995 Triprolidine: 104-week feeding study in rats Fundam Appl Toxicol 27 223 231 8529817 10.1006/faat.1995.1127 1:CAS:528:DyaK2MXotFOmu7c%3D
19. M Habs P Shubik G Eisenbrand 1986 Carcinogenicity of methapyrilene hydrochloride, mepyramine hydrochloride, thenyldiamine hydrochloride, and pyribenzamine hydrochloride in Sprague-Dawley rats J Cancer Res Clin Oncol 111 71 74 3949852 10.1007/BF00402780 1:CAS:528:DyaL28XhvVSjs7w%3D (Pubitemid 16161972)
20. EB Hansen CE Cerniglia WA Korfmacher DW Miller RH Heflich 1987 Microbial transformation of the antihistamine pyrilamine maleate. Formation of potential mammalian metabolites Drug Metab Dispos 15 97 106 2881765 1:CAS:528: DyaL2sXhtlWhs7k%3D (Pubitemid 17014512)
21. EB Hensen Jr RH Heflich WA Korfmacher DW Miller 1988 Microbial transformation of the antihistaminic drug triprolidine hydrochloride J Pharm Sci 77 259 264 10.1002/jps.2600770316
22. M Hite J Algon HM Peck 1977 The effect of cyproheptadine on the chromosomes of human lymphocytes in vitro Arzneim-Fosch 27 1203 1206 1:CAS:528:DyaE2sXltFWgtrk%3D (Pubitemid 8120233)
23. International Agency for Research on Cancer (1972-2007) IARC monographs on the evaluation of carcinogenic risks to humans, vol 1-91. IARC, Lyon
24. International Agency for Research on Cancer (1987) IARC monographs on the evaluation of carcinogenic risks to humans, supplement 7, overall evaluation of carcinogenicity: an updating of IARC monographs, vol 1-42. IARC, Lyon, France
25. International Agency for Research on Cancer (2001) IARC monographs on the evaluation of carcinogenic risks to humans, vol 79, some thyrotropic agents. IARC, Lyon, France, pp 145-159
26. M Ishidate Jr MC Harnois T Sofuni 1988 A comprehensive analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures Mutat Res 195 151 213 3277036 1:CAS:528:DyaL1cXhs1aksbg%3D (Pubitemid 18066068)
27. Iwase Y, Uno Y, Ohkouchi A, Molinier B, Simonnard A, Lebrun C, Moysan F (1998) Mutagenicity and clastogenicity studies with mizolastine. Yakuri to Chiryo 26 (suppl 4):663-672
28. PT Iype R Ray-Chaudhuri W Lijinsky SP Kelley 1982 Inability of methapyrilene to induce sister chromatid exchanges in vitro and in vivo Cancer Res 42 4614 4618 7127299 1:CAS:528:DyaL38XmtFSitLg%3D (Pubitemid 13205964)
29. CD Jackson BN Blackwell 1993 Two-year toxicity study of doxylamine succinate in the fisher 344 rat J Am Coll Toxicol 12 1 11 1:CAS:528: DyaK3sXksVSisLc%3D (Pubitemid 23129344)
30. CD Jackson W Sheldon 1993 Two-year toxicity study of doxylamine succinate in B6C3F1 mice J Am Coll Toxicol 12 311 321 1:CAS:528:DyaK2cXkt1Knurc%3D (Pubitemid 23281553)
31. D Kirkland G Speit 2008 Evaluation of the ability of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. III. Appropriate follow-up testing in vivo Mutat Res 654 114 132 18585956 1:CAS:528:DC%2BD1cXpsVamurc%3D
32. DJ Kirkland M Aardema L Henderson L Muller 2005 Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity Mutat Res 584 1 256 15979392 1:CAS:528:DC%2BD2MXlsl2rur8%3D (Pubitemid 40922793)
33. DJ Kirkland M Hayashi D Jacobson-Kram P Kasper JT MacGregor L Muller Y Uno 2007 Summary of major conclusions from the 4th IWGT, San Francisco, 9-10 September 2005 Mutat Res 627 5 9 17137830 1:CAS:528:DC%2BD2sXls1yjuw%3D%3D (Pubitemid 46091763)
34. H Kubinski GE Gutzke ZO Kubinski 1981 DNA-cell-binding (DCB) assay for suspected carcinogens and mutagens Mutat Res 89 95 136 7290095 10.1016/0165-1218(81)90118-X 1:CAS:528:DyaL3MXktF2ntrk%3D (Pubitemid 11102860)
35. W Lijinsky 1984 Induction of tumours in rats by feeding nitrosatable amines together with sodium nitrite Food Chem Toxicol 22 715 720 6541624 10.1016/0278-6915(84)90198-4 1:CAS:528:DyaL2MXktFemsA%3D%3D (Pubitemid 15208977)
36. W Lijinsky 1984 Chronic toxicity tests of pyrilamine maleate and methapyrilene hydrochloride in F344 rats Food Chem Toxicol 22 27 30 6537934 10.1016/0278-6915(84)90048-6 1:CAS:528:DyaL2cXhtlagu7c%3D (Pubitemid 14187270)
37. W Lijinsky K Yamashita 1988 Lack of binding of methapyrilene and similar antihistamines to rat liver DNA examined by 32P-postlabeling Cancer Res 48 6475 6477 3180063 1:STN:280:DyaL1M%2FivVaqtA%3D%3D
38. KS Loveday MH Lugo MA Resnick BE Anderson E Zeiger 1989 Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro: II. Results with 20 chemicals Environ Mol Mutagen 13 60 94 2642806 10.1002/em.2850130108 1:CAS:528:DyaL1MXhtV2rtbo%3D (Pubitemid 19252658)
39. S Madle SW Dean U Andrae G Brambilla B Burlinson DJ Doolittle C Furihata T Hertner CA McQueen H Mori 1994 Recommendations for the performance of UDS tests in vitro and in vivo Mutat Res 312 263 285 7514739 1:CAS:528: DyaK2cXkt1ylu7c%3D (Pubitemid 24187388)
40. A Martelli E Cajelli A Pino L Robbiano G Brambilla 1984 DNA damage and repair induced in rat hepatocytes primary cultures by five antihistamines and their nitrosation products ICRS Med Sci 12 1054 1055 1:CAS:528: DyaL2MXlsF2htQ%3D%3D (Pubitemid 15218139)
41. Martindale (2007) The complete drug reference, 35th edn. Pharmaceutical Press, London, pp 1-116
42. KH Mavournin DH Blakey MC Cimino MF Salamone JH Heddle 1990 The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. environmental protection agency gene-tox program Mutat Res 239 29 80 2195332 1:CAS:528:DyaK3cXkvFaqs74%3D
43. DB McGregor AG Brown S Howgate D McBride C Riach WJ Caspary 1991 Responses of the L5178Y mouse lymphoma cell forward mutation assay. V: 27 coded chemicals Environ Mol Mutagen 17 196 219 1902415 10.1002/em.2850170309 1:CAS:528:DyaK3MXksVequ70%3D
44. JC Mirsalis 1987 Genotoxicity, toxicity, and carcinogenicity of the antihistamine methapyrilene Mutat Res 185 309 317 3553919 1:CAS:528: DyaL2sXksFWktLw%3D (Pubitemid 17079352)
45. Mortelmans K, Haworth S, Lawlor T, Speck K, Tainer B, Zeiger E (1986) Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ Mutagen 8 (suppl 7):1-119 (Pubitemid 16084504)
46. N Motohashi T Kurihara M Kawase A Hever M Tanaka A Szabo J Nacsa W Yamanaka A Kerim J Molnar 1997 Drug resistance reversal, anti-mutagenicity and antiretroviral effect of phthalimido and chloroethyl-phenothiazines Anticancer Res 17 3537 3543 9413199 1:CAS:528:DyaK1cXkvFOitQ%3D%3D (Pubitemid 27522321)
47. L Müller A Korta S Madle 1989 Mutagenicity testing of doxylamine succinate, an antinauseant drug Toxicol Lett 49 79 86 2815116 10.1016/0378-4274(89)90104-5 (Pubitemid 19243293)
48. L Müller Y Kikuchi G Probst L Schechtman H Shimada T Sofuni D Tweats 1999 ICH-harmonized guidance on genotoxicity testing of pharmaceuticals; evolution, reasoning and impact Mutat Res 436 195 225 10354523 10.1016/S1383-5742(99)00004-6 (Pubitemid 29246090)
49. National Toxicology Program (1986) Toxicology and carcinogenesis studies of chlorpheniramine maleate (CAS No. 113-928) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 317
50. National Toxicology Program (1989) Toxicology and carcinogenesis studies of diphenhydramine hydrochloride (CAS No. 147-24-0) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser 355
51. National Toxicology Program (1993) Technical report series, toxicology and carcinogenesis studies of promethazine hydrochloride (CAS No. 58-33-3) in F344/N rats and B6C3F1 mice (Gavage studies), No. TR-425
52. NCI/NTP Carcinogenesis Technical Report Series (1999) National cancer institute/national toxicology program; US Department of Health and Human Services, TR-485
53. TJ Oberly BJ Bewsey GS Probst 1984 An evaluation of the L5178Y TK ± mouse lymphoma forward mutation assay using 42 chemicals Mutat Res 125 291 306 6700611 10.1016/0027-5107(84)90079-4 1:CAS:528:DyaL2cXhtlCjtrg%3D (Pubitemid 14184386)
54. TJ Oberly JC Scheuring KA Richardson FC Richardson ML Garriot 1993 The evaluation of methapyrilene for bacterial mutation with metabolic activation by Aroclor-induced, methapyrilene-induced and noninduced rat-liver S9 Mutat Res 299 77 84 7680426 10.1016/0165-1218(93)90084-Q 1:CAS:528:DyaK3sXisVOgtr0%3D (Pubitemid 23080909)
55. Physicians (2005) Desk reference, 59th edn. Thomson PDR, Montvale
56. GS Probst SB Neal 1980 The induction of unscheduled DNA synthesis by antihistamines in primary hepatocyte cultures Cance Lett 10 67 73 10.1016/0304-3835(80)90067-1 1:CAS:528:DyaL3cXltVKlurY%3D (Pubitemid 10057415)
57. L Robbiano GM Gazzaniga A Martelli A Pino G Brambilla 1986 DNA-damaging activity of tripelennamine in primary cultures of human hepatocytes Mutat Res 173 229 232 3951472 10.1016/0165-7992(86)90041-2 1:CAS:528:DyaL28Xht1aqs7g%3D (Pubitemid 16161226)
58. RD Snyder 1998 A review and investigation into the mechanistic basis of the genotoxicity of antihistamines Mutat Res 411 235 248 9804962 10.1016/S1383-5742(98)00016-7 1:CAS:528:DyaK1cXmvFWmtbY%3D (Pubitemid 28511386)
59. RD Snyder JW Green 2001 A review of the genotoxicity of marketed pharmaceuticals Mutat Res 488 151 169 11344042 10.1016/S1383-5742(01)00055-2 1:CAS:528:DC%2BD3MXjtlent7g%3D (Pubitemid 32436429)
60. RD Snyder D Ewing LB Hendry 2006 DNA intercalative potential of marketed drugs testing positive in in vitro assays Mutat Res 609 47 59 16857419 1:CAS:528:DC%2BD28XpsVOksLs%3D (Pubitemid 44311611)
61. RD Storer TW McKelvey AR Kraynak MC Elia JE Barnum LS Harmon WW Nichols JG De Luca 1996 Revalidation of the in vitro alkaline elution/rat hepatocyte assay for DNA damage: improved criteria for assessment of cytotoxicity and genotoxicity and results for 81 compounds Mutat Res 368 59 101 8684406 10.1016/0165-1218(95)00070-4 1:CAS:528:DyaK28XktlOgu7c%3D (Pubitemid 26226329)
62. RW Tennant BH Margolin MD Shelby E Zeiger JK Haseman J Spalding W Caspary M Resnick S Stasiewicz B Anderson R Minor 1987 Prediction of chemical carcinogenesis in rodents from in vitro genetic toxicity assays Science 236 933 941 3554512 10.1126/science.3554512 1:CAS:528:DyaL2sXktlCrsb0%3D (Pubitemid 17107941)
63. V Thybaud M Aardema J Clements K Dearfield S Galloway M Hayashi D Jacobson-Kram D Kirkland JT MacGregor D Marzin W Ohyama M Schuler H Suzuki E Zeiger 2007 Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing Mutat Res 627 41 58 17126066 1:CAS:528:DC%2BD2sXls1yjtQ%3D%3D (Pubitemid 46091766)
64. JD Tucker A Auletta MC Cimino KL Dearfield D Jacobson-Kram RR Tice AV Carrano 1993 Sister chromatid exchange: second report of the Gene-Tox Program Mutat Res 297 101 180 7687323 1:CAS:528:DyaK3sXmsVaqu78%3D (Pubitemid 23214970)
65. NT Turner JL Woolley Jr JC Hozier JR Sawyer D Clive 1987 Methapyrilene is a genotoxic carcinogen. Studies on methapyrilene and pyrilamine in the L5178Y/TK ± mouse lymphoma assay Mutat Res 189 285 297 3670332 10.1016/0165-1218(87)90060-7 1:CAS:528:DyaL1cXhslGltQ%3D%3D
66. DJ Tweats D Blakey RH Heflich A Jacobs SD Jacobsen T Morita T Nohmi MR O'Donovan YF Sasaki T Sofuni R Tice 2007 Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests. I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards Mutat Res 627 78 91 17116417 1:CAS:528:DC%2BD2sXls1yitg%3D%3D (Pubitemid 46098931)
67. US Department of Health and Human Sciences (1988) Registry of toxic effects of chemical substances, 1985-1986. Washington
68. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) (1996) Guideline for industry. S2A. Specific aspects of regulatory genotoxicity tests for pharmaceuticals
69. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) (1996) Guidelines for industry. S1A. The need for long-term rodent carcinogenicity studies of pharmaceuticals
70. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) (1997) Guidance for industry. S2B. Genotoxicity: a standard battery for genotoxicity testing of pharmaceuticals
71. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) (1997) Guidance for industry. S1B. Testing for carcinogenicity of pharmaceuticals
72. E Zeiger B Anderson S Haworth T Lawlor K Mortelmans W Speck 1987 Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals Environ Mol Mutagen 9 suppl 9 1 110 1:CAS:528:DyaL2sXktlCrt78%3D (Pubitemid 17115119)
73. E Zeiger JK Haseman MD Shelby BH Margolin RW Tennant 1990 Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals Environ Mol Mutagen 16 suppl 18 1 14 2091921 10.1002/em.2850160502 1:CAS:528:DyaK3MXhvFaktA%3D%3D (Pubitemid 20376833)